Those people who are Expecting or nursing can also be excluded. These limitations are more restricting than they might be for an FDA approval, according to Betty Aldworth, the director of communications at MAPS.No important change in antidepressant efficacy based on QIDS scores at week 6 involving the psilocybin group and escitalopram teamMental he